NASDAQ:CNTB
Connect Biopharma Holdings Ltd American Stock News
$1.34
-0.0200 (-1.47%)
At Close: Apr 26, 2024
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
08:30am, Tuesday, 19'th Mar 2024
SAN DIEGO and TAICANG, China, March 19, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceut
SAN DIEGO, CA and TAICANG, China, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmac
Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?
11:17am, Tuesday, 28'th Nov 2023
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and DexCom (DXCM) have performed compared to their sector so far this year.
SAN DIEGO, CA and TAICANG, China, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmac
Is Connect Biopharma Holdings (CNTB) Outperforming Other Medical Stocks This Year?
11:18am, Monday, 06'th Nov 2023
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this year.
Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year?
11:18am, Friday, 20'th Oct 2023
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and Haemonetics (HAE) have performed compared to their sector so far this year.
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) Upgraded to Buy: What Does It Mean for the Stock?
01:32pm, Friday, 15'th Sep 2023
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Connect Biopharma to Participate in Upcoming September Investor Conferences
06:21pm, Thursday, 24'th Aug 2023
SAN DIEGO and TAICANG, China, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceuti
CNTB Stock Surges Over 20%: Explanation
10:41am, Monday, 20'th Mar 2023
The stock price of Connect Biopharma Holdings Ltd (NASDAQ: CNTB) surged by over 20% intraday today. This is why.
Connect Biopharma stock up more than 40% after trial data
04:38pm, Friday, 17'th Mar 2023
Connect Biopharma Holdings Ltd. CNTB, -3.51% stock rose more than 40% in the extended session Friday after the company said that analysis of a trial involving one of its therapies to treat moderate-to
Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California
08:30am, Monday, 06'th Feb 2023
SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB), a global clinical-stage biopharmaceutical company developing T cell-driven th
Connect Biopharma to Present at the San Francisco Biotech Showcase in January
08:00am, Monday, 19'th Dec 2022
SAN DIEGO and TAICANG, SUZHOU, China, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical
Connect Biopharma To Present at Upcoming Investor and Scientific Conferences
04:05pm, Thursday, 27'th Oct 2022
SAN DIEGO and TAICANG, SUZHOU, China, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB), a global clinical-stage biopharmaceutical company developing T cell-driven th
Conference call and webcast to take place at 5:30 a.m. PDT/8:30 a.m. EDT, tomorrow, Tuesday, October 4
Connect Biopharma Is A Sleeper Heading Into October Data Readout
12:13am, Monday, 26'th Sep 2022
The stock is down 80% year-to-date due to disappointing study results from the company's two lead product candidates, CBP-201 and CBP-307. CBP-307 development has been put on ice.
